Amplifi Vascular, Inc.
What matters now
- $6.8Mannounced
Announced a Series A ($6.8M round) on 9 Oct 2025.
A company that just raised has fresh capital, a new board and new vendors to choose.
FactPress release wires (PR Newswire, GlobeNewswire)For Investors, lenders, service providersFinancing history → - 3 directorsboard
3 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
- Oct 9, 2025Series A · $6.8M (disclosed)Fact Press release · “Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval”
- Aug 21, 2024Form D equity offering · $6.0M (form d sold) · 59 investorsFact Form D · “Amplifi Vascular, Inc. filed Form D/A: $5,960,278 sold of $12,000,000, Biotechnology”
- Jul 28, 2023Form D equity offering · $808,000 (form d sold) · 6 investorsFact Form D · “Amplifi Vascular, Inc. filed Form D/A: $808,000 sold of $8,000,000, Biotechnology”
- Sean Morris Executive Officer/Director sec.gov
- Nathaniel Hagedorn Director Fact
- James Schultz Director Fact
- Steve Braun Director Fact
- Jun 30, 2026Amplifi Vascular, Inc. filed Form D/A: $5,960,278 sold of $12,000,000, BiotechnologyForm D filed Fact Form D
- Mar 26, 2026Amplifi Vascular, Inc. filed Form D/A: $5,910,278 sold of $6,000,000, BiotechnologyForm D filed Fact Form D
- Oct 9, 2025Amplifi Vascular announced Series A of $6,800,000Round announced Fact Press release
- Nov 27, 2024Amplifi Vascular, Inc. filed Form D: $1,543,619 sold of $4,000,000, BiotechnologyForm D filed Fact Form D
- Jun 25, 2024Amplifi Vascular, Inc. filed Form D/A: $808,000 sold of $8,000,000, BiotechnologyForm D filed Fact Form D
Every observation on this company
- Entity type: Corporation Jun 30, 2026 Fact Form D
- Entity type: Corporation Mar 26, 2026 Fact Form D
- Entity type: Corporation Nov 27, 2024 Fact Form D
- Entity type: Corporation Jun 25, 2024 Fact Form D
- Form D industry group: Biotechnology Jun 30, 2026 Fact Form D
- Form D industry group: Biotechnology Mar 26, 2026 Fact Form D
- Form D industry group: Biotechnology Nov 27, 2024 Fact Form D
- Form D industry group: Biotechnology Jun 25, 2024 Fact Form D
- Amendment: true Jun 30, 2026 Fact Form D
- Amendment: true Mar 26, 2026 Fact Form D
- Amendment: false Nov 27, 2024 Fact Form D
- Amendment: true Jun 25, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Jun 30, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Mar 26, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Nov 27, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Jun 25, 2024 Fact Form D
- Incorporated: withinFiveYears Jun 30, 2026 Fact Form D
- Incorporated: withinFiveYears Mar 26, 2026 Fact Form D
- Incorporated: withinFiveYears Nov 27, 2024 Fact Form D
- Incorporated: withinFiveYears Jun 25, 2024 Fact Form D
- Jurisdiction: Delaware Jun 30, 2026 Fact Form D
- Jurisdiction: Delaware Mar 26, 2026 Fact Form D
- Jurisdiction: Delaware Nov 27, 2024 Fact Form D
- Jurisdiction: Delaware Jun 25, 2024 Fact Form D
- Amount sold (Form D): $6.0M Jun 30, 2026 Fact Form D
- Amount sold (Form D): $5.9M Mar 26, 2026 Fact Form D
- Amount sold (Form D): $1.5M Nov 27, 2024 Fact Form D
- Amount sold (Form D): $808,000 Jun 25, 2024 Fact Form D
- Offering amount (Form D): $12.0M Jun 30, 2026 Fact Form D
- Offering amount (Form D): $6.0M Mar 26, 2026 Fact Form D
- Offering amount (Form D): $4.0M Nov 27, 2024 Fact Form D
- Offering amount (Form D): $8.0M Jun 25, 2024 Fact Form D
- Exemptions: 06b Jun 30, 2026 Fact Form D
- Exemptions: 06b Mar 26, 2026 Fact Form D
- Exemptions: 06b Nov 27, 2024 Fact Form D
- Exemptions: 06b Jun 25, 2024 Fact Form D
- First sale: 2024-08-21 Jun 30, 2026 Fact Form D
- First sale: 2024-08-21 Mar 26, 2026 Fact Form D
- First sale: 2024-08-21 Nov 27, 2024 Fact Form D
- First sale: 2023-07-28 Jun 25, 2024 Fact Form D
- Investors (Form D): 59 Jun 30, 2026 Fact Form D
- Investors (Form D): 59 Mar 26, 2026 Fact Form D
- Investors (Form D): 23 Nov 27, 2024 Fact Form D
- Investors (Form D): 6 Jun 25, 2024 Fact Form D
- Minimum investment (Form D): 0 Jun 30, 2026 Fact Form D
- Minimum investment (Form D): 0 Mar 26, 2026 Fact Form D
- Minimum investment (Form D): 0 Nov 27, 2024 Fact Form D
- Minimum investment (Form D): 0 Jun 25, 2024 Fact Form D
- Securities offered: Debt, option Jun 30, 2026 Fact Form D
- Securities offered: Debt, option Mar 26, 2026 Fact Form D
- Securities offered: Debt, option Nov 27, 2024 Fact Form D
- Securities offered: equity Jun 25, 2024 Fact Form D
- Office address: Jun 30, 2026 Fact Form D
- Office address: Mar 26, 2026 Fact Form D
- Office address: Nov 27, 2024 Fact Form D
- Office address: Jun 25, 2024 Fact Form D
- Round announced: Series A $6,800,000 Oct 9, 2025 Fact Press release
- Year of incorporation: 2023 Jun 30, 2026 Fact Form D
- Year of incorporation: 2023 Mar 26, 2026 Fact Form D
- Year of incorporation: 2023 Nov 27, 2024 Fact Form D
- Year of incorporation: 2023 Jun 25, 2024 Fact Form D
Record history
- Form D filed2026-06-30source on record
- Form D filed2026-03-26source on record
- Round announced2025-10-09source on record
+2 more changes on this record's ledger
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.